Joshua Kahwor Au, MD
Otolaryngology · Alamo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 14 years
- University of California, Geffen School of Medicine, 2012
Offices
2 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Au’s office at (925) 932-6330 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A127683 · Current
Licensed to practise in California · since 2013 · expires 2027-10-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Bay Area Surgical Specialists Services, LLC DBA BASS Surgery CenterAmbulatory Surgery Center · Walnut Creek, CA2.72% owner since 2024 · accredited by AAAHCInitial Accreditation2 inspections, 2 with deficiencies · last 2025-06-27
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Otolaryngology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$230,266
Medicare paid this office $230,266 for 798 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 369 | $57,180 | $85 |
| New patient visit (30+ min) | 320 | $32,015 | $100 |
| Diagnostic exam of nasal passages using an endoscope | 78 | $24,788 | $191 |
| New patient visit (45+ min) | 159 | $23,520 | $148 |
| Return visit (30+ min) | 114 | $17,208 | $118 |
See all 15 services
| Short return visit (20+ min) | 369 | $57,180 | $85 |
| New patient visit (30+ min) | 320 | $32,015 | $100 |
| Diagnostic exam of nasal passages using an endoscope | 78 | $24,788 | $191 |
| New patient visit (45+ min) | 159 | $23,520 | $148 |
| Return visit (30+ min) | 114 | $17,208 | $118 |
| Diagnostic exam of voice box using a flexible endoscope | 90 | $14,151 | $136 |
| Removal of impacted ear wax | 161 | $10,368 | $44 |
| Comprehensive hearing and speech recognition test | 265 | $9,410 | $34 |
| Removal of inflamed or infected skin, up to 10% of body surface | 35 | $4,774 | $59 |
| Test to assess middle ear function | 245 | $4,088 | $16 |
| Simple control of nose bleed | 15 | $2,766 | $154 |
| Exam of ear using a microscope | 39 | $2,679 | $31 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 20 | $1,010 | $50 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $585 | $34 |
| Test for eardrum and muscle function | 24 | $523 | $22 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of tissue | 51 | More than 79% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 125 | 152 | 204 | 196 | 172 | 236 |
| Diagnostic exam of nasal passages using an endoscope | 110 | 95 | 127 | 151 | 159 | 130 |
| Diagnostic exam of voice box using a flexible endoscope | 118 | 79 | 127 | 130 | 113 | 104 |
| Removal of inflamed or infected skin, up to 10% of body surface | 35 | 85 | 71 | 57 | 77 | 81 |
| Simple control of nose bleed | 17 | – | – | 15 | 15 | 18 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | – | – | – | 22 | 16 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
798 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 13% · Women 57% · Also on Medicaid 11% · Health risk score 0.98. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 65% · Diabetes 20% · Coronary heart disease 18% · Atrial fibrillation 17% · Chronic kidney disease 16% · Cancer 16% · Depression 14% · COPD 11% · Heart failure 10% · Stroke 7% · Dementia 4%.
The office billed $878,865, Medicare allowed $306,776 and paid $230,266; for 2,655 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 798 | 2,655 | 76 | 0.98 | $878,865 | $230,266 |
| 2023 | 786 | 2,757 | 75 | 0.91 | $1,014,808 | $255,877 |
| 2022 | 859 | 2,572 | 75 | 1.10 | $948,181 | $232,988 |
| 2021 | 815 | 2,499 | 75 | 1.09 | $907,853 | $235,616 |
| 2020 | 584 | 1,862 | 75 | 1.17 | $605,419 | $151,018 |
| 2019 | 559 | 1,720 | 75 | 1.19 | $599,884 | $149,200 |
| 2018 | 503 | 1,562 | 74 | 1.17 | $502,282 | $127,714 |
| 2017 | 207 | 518 | 75 | 1.27 | $153,772 | $42,156 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 18 services
| Short return visit (20+ min) | 337 | $47,612 | $82 |
| New patient visit (45+ min) | 218 | $30,943 | $142 |
| Diagnostic exam of nasal passages using an endoscope | 119 | $30,796 | $194 |
| Return visit (30+ min) | 187 | $28,997 | $116 |
| New patient visit (30+ min) | 264 | $25,751 | $98 |
| Diagnostic exam of voice box using a flexible endoscope | 92 | $14,771 | $131 |
| Comprehensive hearing and speech recognition test | 283 | $10,077 | $34 |
| Removal of impacted ear wax | 134 | $7,231 | $42 |
| Reshaping of nasal cartilage | 12 | $6,153 | $513 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $5,816 | $363 |
| Removal of inflamed or infected skin, up to 10% of body surface | 33 | $4,249 | $55 |
| Test to assess middle ear function | 248 | $4,137 | $16 |
| Exam of ear using a microscope | 44 | $3,051 | $30 |
| Simple control of nose bleed | 14 | $2,073 | $138 |
| Removal of nasal air passage under lining tissue | 12 | $1,477 | $123 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 25 | $1,292 | $52 |
| Repositioning exercises of head for treatment of dizziness, each day | 21 | $990 | $41 |
| Test for eardrum and muscle function | 23 | $454 | $19 |
2022: 16 services
| Short return visit (20+ min) | 347 | $42,678 | $79 |
| New patient visit (45+ min) | 261 | $36,365 | $139 |
| Diagnostic exam of nasal passages using an endoscope | 123 | $28,063 | $186 |
| Return visit (30+ min) | 168 | $25,356 | $110 |
| New patient visit (30+ min) | 263 | $23,546 | $90 |
| Diagnostic exam of voice box using a flexible endoscope | 120 | $16,727 | $129 |
| Removal of impacted ear wax | 167 | $8,022 | $41 |
| Comprehensive hearing and speech recognition test | 229 | $7,907 | $34 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $6,915 | $314 |
| Test to assess middle ear function | 194 | $3,065 | $15 |
| Removal of inflamed or infected skin, up to 10% of body surface | 32 | $3,010 | $53 |
| Exam of ear using a microscope | 37 | $1,877 | $28 |
| Simple control of nose bleed | 12 | $1,873 | $125 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 26 | $1,195 | $46 |
| Test for eardrum and muscle function | 38 | $772 | $20 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $576 | $38 |
2021: 14 services
| Short return visit (20+ min) | 323 | $43,207 | $80 |
| New patient visit (45+ min) | 233 | $33,910 | $146 |
| Return visit (30+ min) | 188 | $28,843 | $117 |
| New patient visit (30+ min) | 287 | $27,322 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 97 | $25,291 | $199 |
| Diagnostic exam of voice box using a flexible endoscope | 108 | $15,954 | $126 |
| Removal of impacted ear wax | 166 | $8,457 | $41 |
| Comprehensive hearing and speech recognition test | 188 | $6,891 | $35 |
| Removal of inflamed or infected skin, up to 10% of body surface | 40 | $3,611 | $51 |
| Exam of ear using a microscope | 45 | $2,242 | $29 |
| Test to assess middle ear function | 136 | $2,237 | $16 |
| Repositioning exercises of head for treatment of dizziness, each day | 26 | $1,091 | $40 |
| Test for eardrum and muscle function | 48 | $1,010 | $20 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $604 | $46 |
2020: 13 services
| Short return visit (20+ min) | 288 | $34,156 | $65 |
| New patient visit (30+ min) | 275 | $24,068 | $88 |
| Diagnostic exam of nasal passages using an endoscope | 76 | $16,658 | $175 |
| Return visit (30+ min) | 69 | $10,231 | $100 |
| New patient visit (45+ min) | 74 | $10,079 | $136 |
| Diagnostic exam of voice box using a flexible endoscope | 63 | $8,779 | $111 |
| Removal of impacted ear wax | 117 | $6,213 | $41 |
| Removal of inflamed or infected skin, up to 10% of body surface | 37 | $4,206 | $49 |
| Comprehensive hearing and speech recognition test | 98 | $3,269 | $32 |
| Exam of ear using a microscope | 40 | $2,552 | $28 |
| Test to assess middle ear function | 84 | $1,174 | $13 |
| Repositioning exercises of head for treatment of dizziness, each day | 21 | $866 | $41 |
| Test for eardrum and muscle function | 15 | $337 | $21 |
2019: 15 services
| Short return visit (20+ min) | 280 | $30,810 | $63 |
| New patient visit (30+ min) | 285 | $25,890 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 82 | $21,067 | $192 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $12,368 | $105 |
| New patient visit (45+ min) | 53 | $7,344 | $139 |
| Return visit (30+ min) | 52 | $6,711 | $97 |
| Removal of impacted ear wax | 95 | $4,936 | $39 |
| Comprehensive hearing and speech recognition test | 92 | $3,179 | $32 |
| Simple control of nose bleed | 16 | $2,089 | $123 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,052 | $108 |
| Removal of inflamed or infected skin, up to 10% of body surface | 24 | $1,837 | $52 |
| Test to assess middle ear function | 91 | $1,296 | $13 |
| Exam of ear using a microscope | 27 | $1,123 | $30 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,094 | $64 |
| Repositioning exercises of head for treatment of dizziness, each day | 24 | $931 | $39 |
2018: 14 services
| New patient visit (30+ min) | 316 | $27,050 | $86 |
| Short return visit (20+ min) | 225 | $26,708 | $65 |
| Diagnostic exam of nasal passages using an endoscope | 56 | $13,866 | $198 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $10,097 | $102 |
| Return visit (30+ min) | 41 | $5,173 | $98 |
| New patient visit (45+ min) | 30 | $4,377 | $146 |
| Removal of impacted ear wax | 89 | $4,364 | $41 |
| Simple control of nose bleed | 22 | $3,269 | $117 |
| Comprehensive hearing and speech recognition test | 90 | $2,903 | $32 |
| Removal of inflamed or infected skin, up to 10% of body surface | 23 | $2,750 | $52 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,693 | $121 |
| Exam of ear using a microscope | 25 | $1,599 | $29 |
| Test to assess middle ear function | 90 | $1,180 | $13 |
| Repositioning exercises of head for treatment of dizziness, each day | 24 | $935 | $35 |
2017: 8 services
| New patient visit (30+ min) | 144 | $14,085 | $98 |
| Short return visit (20+ min) | 71 | $5,711 | $66 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $5,120 | $205 |
| Diagnostic exam of voice box using a flexible endoscope | 39 | $4,108 | $103 |
| Removal of impacted ear wax | 41 | $1,936 | $40 |
| Comprehensive hearing and speech recognition test | 48 | $1,652 | $34 |
| Return visit (30+ min) | 12 | $1,082 | $90 |
| Test to assess middle ear function | 47 | $630 | $13 |
Medicaid work
$5,402 in 2024
Medicaid paid $5,402 for 56 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 28 | $3,210 |
| Short return visit (20+ min) | 28 | $2,193 |
| 2024 | 56 | 2 | 14 | $5,402 |
| 2023 | 119 | 3 | 16 | $11,905 |
| 2022 | 160 | 4 | 17 | $21,591 |
| 2020 | 29 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 80 | $6,752 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $2,591 |
| New patient visit (30+ min) | 27 | $2,563 |
2022
| New patient visit (45+ min) | 57 | $10,745 |
| Short return visit (20+ min) | 61 | $6,477 |
| New patient visit (30+ min) | 29 | $3,797 |
| Comprehensive audiometry threshold evaluation and speech recognition | 13 | $572 |
2020
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 29 | $0 |
Drugs they prescribed that Part D paid
$23,856
Pharmacies billed $23,856 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (12 of 856) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
837 generic and 19 brand-name prescriptions · $23,856 in drug cost · 104 antibiotic prescriptions to 63 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xhance | 11 | $7,876 | $716 |
| Fluticasone Propionate | 324 | $5,137 | $16 |
| Azelastine | 65 | $1,693 | $26 |
| Ofloxacin | 41 | $1,555 | $38 |
| Ipratropium | 48 | $1,257 | $26 |
See all 17 drugs
| Xhance | 11 | $7,876 | $716 |
| Fluticasone Propionate | 324 | $5,137 | $16 |
| Azelastine | 65 | $1,693 | $26 |
| Ofloxacin | 41 | $1,555 | $38 |
| Ipratropium | 48 | $1,257 | $26 |
| Triamcinolone Acetonide | 31 | $913 | $29 |
| Clotrimazole | 19 | $468 | $25 |
| Acetic Acid | 21 | $388 | $18 |
| Amoxicillin-Clavulanate Potass | 44 | $348 | $8 |
| Montelukast | 28 | $344 | $12 |
| Doxycycline Hyclate | 28 | $308 | $11 |
| Famotidine | 32 | $229 | $7 |
| Triamterene-Hydrochlorothiazid | 26 | $183 | $7 |
| Methylprednisolone | 23 | $165 | $7 |
| Mupirocin | 13 | $106 | $8 |
| Prednisone | 19 | $82 | $4 |
| Hydrocodone-Acetaminophen | 11 | $31 | $3 |
Year by year
| 2024 | 856 | 351 | 1% (12) | 2% | $23,856 |
| 2023 | 853 | 347 | 3% (23) | 2% | $22,603 |
| 2022 | 741 | 311 | 3% (20) | None | $19,533 |
| 2021 | 721 | 311 | 3% (18) | None | $19,000 |
| 2020 | 658 | 306 | 3% (20) | 3% | $15,384 |
| 2019 | 600 | 287 | 3% (18) | 4% | $16,106 |
| 2018 | 401 | 198 | 4% (15) | 3% | $9,943 |
| 2017 | 257 | 153 | 26% (66) | None | $5,385 |
| 2016 | 37 | 24 | 49% (18) | None | $314 |
| 2013 | 40 | 15 | 0% (0) | None | $4,238 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Fluticasone Propionate | 340 | $6,160 | $18 |
| Azelastine | 64 | $2,664 | $42 |
| Ofloxacin | 39 | $1,401 | $36 |
| Ipratropium | 41 | $1,211 | $30 |
| Triamcinolone Acetonide | 37 | $665 | $18 |
| Doxycycline Hyclate | 38 | $511 | $13 |
| Amoxicillin-Clavulanate Potass | 42 | $454 | $11 |
| Acetic Acid | 16 | $339 | $21 |
| Triamterene-Hydrochlorothiazid | 22 | $291 | $13 |
| Montelukast | 17 | $261 | $15 |
| Methylprednisolone | 36 | $258 | $7 |
| Famotidine | 24 | $243 | $10 |
| Prednisone | 17 | $101 | $6 |
| Hydrocodone-Acetaminophen | 22 | $95 | $4 |
| Cephalexin | 15 | $73 | $5 |
2022: 13 drugs
| Fluticasone Propionate | 322 | $5,764 | $18 |
| Azelastine | 78 | $3,347 | $43 |
| Ofloxacin | 33 | $2,186 | $66 |
| Ipratropium | 25 | $1,454 | $58 |
| Triamcinolone Acetonide | 28 | $950 | $34 |
| Amoxicillin-Clavulanate Potass | 36 | $455 | $13 |
| Doxycycline Hyclate | 31 | $405 | $13 |
| Triamterene-Hydrochlorothiazid | 30 | $289 | $10 |
| Methylprednisolone | 26 | $285 | $11 |
| Montelukast | 12 | $246 | $21 |
| Prednisone | 15 | $104 | $7 |
| Hydrocodone-Acetaminophen | 18 | $92 | $5 |
| Cephalexin | 15 | $76 | $5 |
2021: 14 drugs
| Fluticasone Propionate | 273 | $5,211 | $19 |
| Azelastine | 77 | $3,261 | $42 |
| Ofloxacin | 26 | $1,726 | $66 |
| Triamcinolone Acetonide | 37 | $1,226 | $33 |
| Omeprazole | 59 | $1,106 | $19 |
| Amoxicillin-Clavulanate Potass | 25 | $379 | $15 |
| Doxycycline Hyclate | 16 | $283 | $18 |
| Triamterene-Hydrochlorothiazid | 21 | $204 | $10 |
| Methylprednisolone | 24 | $195 | $8 |
| Montelukast | 12 | $190 | $16 |
| Pantoprazole | 12 | $181 | $15 |
| Prednisone | 25 | $149 | $6 |
| Hydrocodone-Acetaminophen | 17 | $119 | $7 |
| Cephalexin | 14 | $62 | $4 |
2020: 11 drugs
| Fluticasone Propionate | 216 | $4,189 | $19 |
| Azelastine | 71 | $3,075 | $43 |
| Omeprazole | 87 | $1,667 | $19 |
| Ofloxacin | 25 | $1,055 | $42 |
| Triamcinolone Acetonide | 15 | $536 | $36 |
| Acetic Acid | 21 | $506 | $24 |
| Doxycycline Hyclate | 30 | $486 | $16 |
| Amoxicillin-Clavulanate Potass | 20 | $216 | $11 |
| Hydrocodone-Acetaminophen | 18 | $109 | $6 |
| Prednisone | 15 | $89 | $6 |
| Cephalexin | 12 | $56 | $5 |
2019: 13 drugs
| Fluticasone Propionate | 197 | $2,924 | $15 |
| Azelastine | 69 | $2,627 | $38 |
| Ofloxacin | 22 | $1,171 | $53 |
| Omeprazole | 58 | $1,139 | $20 |
| Ipratropium | 15 | $554 | $37 |
| Amoxicillin-Clavulanate Potass | 34 | $428 | $13 |
| Methylprednisolone | 26 | $262 | $10 |
| Doxycycline Hyclate | 14 | $124 | $9 |
| Clindamycin | 13 | $114 | $9 |
| Prednisone | 14 | $96 | $7 |
| Hydrocodone-Acetaminophen | 16 | $90 | $6 |
| Amoxicillin | 15 | $55 | $4 |
| Cephalexin | 11 | $46 | $4 |
2018: 9 drugs
| Azelastine | 34 | $1,736 | $51 |
| Fluticasone Propionate | 131 | $1,493 | $11 |
| Ofloxacin | 16 | $1,434 | $90 |
| Omeprazole | 43 | $857 | $20 |
| Amoxicillin-Clavulanate Potass | 19 | $272 | $14 |
| Clindamycin | 13 | $173 | $13 |
| Methylprednisolone | 13 | $155 | $12 |
| Hydrocodone-Acetaminophen | 12 | $84 | $7 |
| Cephalexin | 11 | $54 | $5 |
2017: 7 drugs
| Omeprazole | 24 | $571 | $24 |
| Fluticasone Propionate | 38 | $540 | $14 |
| Amoxicillin-Clavulanate Potass | 24 | $332 | $14 |
| Methylprednisolone | 20 | $284 | $14 |
| Hydrocodone-Acetaminophen | 48 | $276 | $6 |
| Oxycodone | 13 | $161 | $12 |
| Cephalexin | 17 | $73 | $4 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 13 | $124 | $10 |
Money from drug and device companies
$110 in 2025
| 2025 | 1 | 5 | None | $110 |
| 2024 | 1 | 1 | None | $82 |
| 2023 | 4 | 4 | None | $177 |
| 2022 | 1 | 1 | None | $31 |
| 2021 | 1 | 1 | None | $23 |
| 2020 | 3 | 4 | None | $72 |
| 2019 | 2 | 2 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Halo | $110 | 5 payments
|
See all 5 published payments
| Smith+Nephew | Meals · 2025-12-16 | Halo | $18 |
| Smith+Nephew | Meals · 2025-12-09 | Halo | $17 |
| Smith+Nephew | Meals · 2025-11-15 | Halo | $21 |
| Smith+Nephew | Meals · 2025-07-03 | Halo | $19 |
| Smith+Nephew | Meals · 2025-05-19 | Halo | $35 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $82
| Medtronic | Venaseal | $82 | 1 payment
|
2023: $177
| Medtronic | Venaseal | $105 | 1 payment
|
| Inspire Medical Systems | Inspire | $37 | 1 payment
|
| Optinose US | Xhance | $19 | 1 payment
|
| Smith+Nephew | Halo | $16 | 1 payment
|
2022: $31
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $31 | 1 payment
|
2021: $23
| Optinose US | Xhance | $23 | 1 payment
|
2020: $72
| OptiNose US | Xhance | $38 | 2 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $20 | 1 payment
|
| Genzyme | Dupixent | $14 | 1 payment
|
2019: $47
| Amgen | Repatha | $28 | 1 payment
|
| Intersect ENT | Sinuva | $20 | 1 payment
|
Checkups this office reported
17 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 92.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 22%That's few of the people this applied to. | 41 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 74%That's more than half. | 788 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 2%That's few of the people this applied to. Better on this measure. | 234 |
| Breast cancer screeningEligible women who got a mammogram | 81%That's most of the people this applied to. | 781 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 54%That's more than half. | 880 |
| Checked for fall riskOlder patients screened for fall risk | 52%That's more than half. | 1,235 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 25% | 51 |
| Colon cancer screeningEligible adults who got a colon cancer test | 67%That's more than half. | 1,650 |
See the other 9 measures
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 37%That's less than half. | 2,346 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 33%That's less than half. | 206 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 27%That's less than half. Better on this measure. | 206 |
| HIV screeningEligible patients who were screened for HIV | 24%That's few of the people this applied to. | 1,880 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 5,010 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 99%That's most of the people this applied to. | 944 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 532 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 76%That's most of the people this applied to. | 866 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 47%That's less than half. | 2,939 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1366701385
- Licence
- CA A127683California A127683: Current · expires 2027-10-31
- Trained
- University of California, Geffen School of Medicine, 2012 · 14 years ago
- Group
- Bass Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2301 Camino Ramon Ste 205, San Ramon, CA, 94583
- NPI first listed
- 2012-05-11
- NPI last updated
- 2024-11-12
- NPI record certified
- 2024-11-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6600 Lone Tree Way, Brentwood, CA, 94513 · 400 Taylor Blvd Ste 303, Pleasant Hill, CA, 94523 · 365 Lennon Ln Ste 280, Walnut Creek, CA, 94598